Home ContractsRDE233 -Staphylococcus aureus in cases of bovine m…

RDE233 -Staphylococcus aureus in cases of bovine mastitis and in humans

WAC ID:154818

Public SectorAward noticeClosed

Source:	Contracts Finder
Notice Type:	Award notice
Buyer:	VMD
Main Category:	Services
Procurement Method:	Call-off from a framework agreement
Tender Status:	Closed
Estimated Value (ex. VAT):	Not specified
Release Date:	9 November 2023
Application Deadline:	30 January 2023
Contract Start Date:	1 February 2023

Procurement timeline

All 2 notices for this procurement, oldest first.

View full lifecycle →

Contract award notice· 9 Nov 2023
RDE233 -Staphylococcus aureus in cases of bovine mastitis and in humans
Contract award notice· 9 Nov 2023Viewing
RDE233 -Staphylococcus aureus in cases of bovine mastitis and in humans

Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.

View Original Notice

Access the full notice on the official portal

🤝 Need a consortium or subcontracting partner?

SMEs & Primes team up to win opportunities like this. Find partners on the board.

Find partners →

Award outcome

Awarded to

SAC Commercial LtdGB-CFS-264061

Award value:	£39,463
Award decision date:	30 January 2023
Award status:	Active

Contracting Authority

Organisation

VMD

Submission Details

Description

The VMD seeks to commission research into this area, the objectives of which would be to: • Determine the rates of and changes in antimicrobial resistance in S. aureus isolates from bovine mastitis over the period 2007-2022, including sensitivity testing of isolates not previously done. • Initially genotype additional bovine mastitis isolates of S. aureus by spa typing, in particular those before 2015 and after 2018. • Investigate the sharing of spa types circulating within bovine and human populations. • Select bovine mastitis and human S. aureus strains for whole genome sequencing, based on spa type, to obtain a better resolution of the population structure and determine the presence of AMR genes and host adaptation and virulence factors. Where possible, this may include following individual farms over the period of study. This contract was awarded by VMD.